Improving MS patients’ understanding of treatment risks and benefits in clinical consultations: A randomised crossover trial

Gurpreet K. Reen, Eli Silber, Dawn W. Langdon

Research output: Contribution to journalArticlepeer-review

19 Downloads (Pure)
Original languageEnglish
Article number102737
Number of pages8
JournalMultiple sclerosis and related disorders
Early online date12 Jan 2021
Publication statusPublished - Apr 2021


  • disease-modifying drugs
  • medical decision making
  • Multiple sclerosis
  • randomised crossover trial
  • treatment understanding

Cite this